naltrexone has been researched along with Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, KC; Chiu, KB; Didier, PJ; Lee, KM; MacLean, AG | 1 |
| de Costa, B; Long, JB; Martinez-Arizala, A; Rice, KC; Rigamonti, DD | 1 |
2 other study(ies) available for naltrexone and Atrophy
| Article | Year |
|---|---|
Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques.
Topics: Animals; Astrocytes; Atrophy; Brain; Female; Gray Matter; Macaca mulatta; Male; Naltrexone; Self-Injurious Behavior; Toll-Like Receptor 2; White Matter | 2015 |
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
Topics: Animals; Atrophy; Dynorphins; Hindlimb; Ischemia; Male; Naltrexone; Narcotic Antagonists; Paralysis; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Spinal Cord Diseases | 1989 |